CPB (NYSE:CPF - Get Free Report) had its price objective upped by equities research analysts at Keefe, Bruyette & Woods from $36.00 to $37.00 in a research report issued on Thursday,Benzinga reports. The firm currently has a "market perform" rating on the financial services provider's stock. Keefe, Bruyette & Woods' target price would indicate a potential upside of 9.09% from the stock's current price.
A number of other brokerages also recently weighed in on CPF. Piper Sandler reduced their price objective on shares of CPB from $39.00 to $37.00 and set an "overweight" rating for the company in a report on Thursday, April 2nd. Weiss Ratings restated a "buy (b)" rating on shares of CPB in a research report on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat.com, CPB presently has a consensus rating of "Moderate Buy" and an average price target of $37.00.
Check Out Our Latest Research Report on CPB
CPB Price Performance
CPF traded up $0.63 on Thursday, hitting $33.92. 46,268 shares of the company were exchanged, compared to its average volume of 172,843. CPB has a fifty-two week low of $23.42 and a fifty-two week high of $35.01. The firm has a market capitalization of $896.79 million, a P/E ratio of 11.86 and a beta of 0.88. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.85 and a current ratio of 0.85. The business's fifty day moving average is $32.48 and its 200 day moving average is $31.21.
CPB (NYSE:CPF - Get Free Report) last announced its quarterly earnings data on Wednesday, January 28th. The financial services provider reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.12. The business had revenue of $76.29 million for the quarter, compared to the consensus estimate of $75.43 million. CPB had a net margin of 21.17% and a return on equity of 13.64%. As a group, sell-side analysts anticipate that CPB will post 2.75 EPS for the current year.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in the stock. Hsbc Holdings PLC bought a new stake in shares of CPB during the 4th quarter valued at about $3,171,000. Invesco Ltd. increased its stake in CPB by 122.4% in the 4th quarter. Invesco Ltd. now owns 185,893 shares of the financial services provider's stock worth $5,792,000 after purchasing an additional 102,301 shares during the period. Mercer Global Advisors Inc. ADV purchased a new position in CPB in the 4th quarter worth approximately $242,000. Empowered Funds LLC grew its stake in CPB by 9.4% in the fourth quarter. Empowered Funds LLC now owns 119,889 shares of the financial services provider's stock worth $3,736,000 after purchasing an additional 10,337 shares during the period. Finally, Numerai GP LLC purchased a new stake in CPB in the fourth quarter worth about $316,000. Institutional investors own 88.42% of the company's stock.
CPB Company Profile
(
Get Free Report)
Charoen Pokphand Foods Public Company Limited NYSE: CPF is a Thailand‐based integrated agro‐industrial and food conglomerate. Headquartered in Bangkok, the company is a subsidiary of the Charoen Pokphand Group and has grown into one of the world's leading producers of livestock feed, meat and seafood products. CPF's businesses span animal feed milling, animal breeding and hatchery operations, meat and seafood processing, and the distribution of fresh, frozen and value‐added food products.
CPF's product portfolio includes poultry, swine and aquaculture feed; fresh and frozen chicken and pork; shrimp and other seafood; as well as ready‐to‐eat and ready‐to‐cook food items.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CPB, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CPB wasn't on the list.
While CPB currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.